Summary?
GeneID 51567
Symbol TDP2
Synonyms AD022|EAP2|EAPII|TTRAP|dJ30M3.3|hTDP2
Description tyrosyl-DNA phosphodiesterase 2
Reference MIM:605764|HGNC:HGNC:17768|Ensembl:ENSG00000111802|HPRD:05771|Vega:OTTHUMG00000014360
Gene type protein-coding
Map location 6p22.3-p22.1
Pascal p-value 0.007
eGene Myers' cis & trans

Gene in Data Sources
Gene set name Method of gene set Description Info
CV:PGCnp Genome-wide Association Study GWAS

Section I. Genetics and epigenetics annotation

@eQTL annotation

SNP ID Chromosome Position eGene Gene Entrez ID pvalue qvalue TSS distance eQTL type
rs9882137 chr3 29494146 TDP2 51567 0.11 trans
rs4491879 chr3 189373908 TDP2 51567 0.18 trans
rs4505678 chr3 189374356 TDP2 51567 0.12 trans
rs17139868 chr7 117079228 TDP2 51567 0.01 trans
rs1999514 chr13 84147878 TDP2 51567 0.12 trans
rs12327665 chr19 39622639 TDP2 51567 0.05 trans

Section II. Transcriptome annotation

General gene expression (GTEx)

Not available

Gene expression of temporal and spatial changes (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.

No co-expressed genes in brain regions


Section III. Gene Ontology annotation

Molecular function GO term Evidence Neuro keywords PubMed ID
GO:0003714 transcription corepressor activity TAS 10764746
Biological process GO term Evidence Neuro keywords PubMed ID
GO:0007166 cell surface receptor linked signal transduction TAS 10764746
Cellular component GO term Evidence Neuro keywords PubMed ID
GO:0005634 nucleus IEA -

Section IV. Protein-protein interaction annotation

Interactors Aliases B Official full name B Experimental Source PubMed ID
CD40 Bp50 | CDW40 | MGC9013 | TNFRSF5 | p50 CD40 molecule, TNF receptor superfamily member 5 - HPRD,BioGRID 10764746
ETS1 ETS-1 | EWSR2 | FLJ10768 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) EAPII interacts with ETS1. BIND 12743594
ETS1 ETS-1 | EWSR2 | FLJ10768 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) - HPRD,BioGRID 12743594
ETS1 ETS-1 | EWSR2 | FLJ10768 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) EAPII interacts with p42-ETS1. BIND 12743594
ETS2 ETS2IT1 v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) ETS2 wi交互th EAPII. BIND 12743594
FLI1 EWSR2 | SIC-1 Friend leukemia virus integration 1 FLI1 interacts with EAPII. BIND 12743594
SUMO1 DAP-1 | GMP1 | OFC10 | PIC1 | SENP2 | SMT3 | SMT3C | SMT3H3 | SUMO-1 | UBL1 SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) SUMO-1 interacts with TTRAP. BIND 14609633
SUMO1 DAP-1 | GMP1 | OFC10 | PIC1 | SENP2 | SMT3 | SMT3C | SMT3H3 | SUMO-1 | UBL1 SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) Two-hybrid BioGRID 14609633
TNFRSF1B CD120b | TBPII | TNF-R-II | TNF-R75 | TNFBR | TNFR1B | TNFR2 | TNFR80 | p75 | p75TNFR tumor necrosis factor receptor superfamily, member 1B - HPRD,BioGRID 10764746
TNFRSF8 CD30 | D1S166E | KI-1 tumor necrosis factor receptor superfamily, member 8 - HPRD,BioGRID 10764746
TRAF2 MGC:45012 | TRAP | TRAP3 TNF receptor-associated factor 2 - HPRD,BioGRID 10764746
TRAF3 CAP-1 | CD40bp | CRAF1 | LAP1 TNF receptor-associated factor 3 Affinity Capture-Western BioGRID 10764746
TRAF5 MGC:39780 | RNF84 TNF receptor-associated factor 5 - HPRD,BioGRID 10764746
TRAF6 MGC:3310 | RNF85 TNF receptor-associated factor 6 - HPRD,BioGRID 10764746
UBE2I C358B7.1 | P18 | UBC9 ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) Two-hybrid BioGRID 14609633
UBE2I C358B7.1 | P18 | UBC9 ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) Ubc9 interacts with TTRAP. BIND 14609633


Section V. Pathway annotation

Pathway name Pathway size # SZGR 2.0 genes in pathway Info
PID CD40 PATHWAY 31 26 All SZGR 2.0 genes in this pathway
HORIUCHI WTAP TARGETS DN 310 188 All SZGR 2.0 genes in this pathway
PAPASPYRIDONOS UNSTABLE ATEROSCLEROTIC PLAQUE UP 52 36 All SZGR 2.0 genes in this pathway
BERENJENO通过RHOA转换 536 340 All SZGR 2.0 genes in this pathway
GRASEMANN RETINOBLASTOMA WITH 6P AMPLIFICATION 14 14 All SZGR 2.0 genes in this pathway
SCHLOSSER SERUM RESPONSE DN 712 443 All SZGR 2.0 genes in this pathway
PATIL LIVER CANCER 747 453 All SZGR 2.0 genes in this pathway
NUYTTEN NIPP1 TARGETS DN 848 527 All SZGR 2.0 genes in this pathway
SHEN SMARCA2 TARGETS UP 424 268 All SZGR 2.0 genes in this pathway
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN 73 45 All SZGR 2.0 genes in this pathway
MOREAUX MULTIPLE MYELOMA BY TACI DN 172 107 All SZGR 2.0 genes in this pathway
BLALOCK ALZHEIMERS DISEASE DN 1237 837 All SZGR 2.0 genes in this pathway
BONOME OVARIAN CANCER SURVIVAL OPTIMAL DEBULKING 246 152 All SZGR 2.0 genes in this pathway
MUELLER PLURINET 299 189 All SZGR 2.0 genes in this pathway
KIM ALL DISORDERS CALB1 CORR UP 548 370 All SZGR 2.0 genes in this pathway
PILON KLF1 TARGETS DN 1972 1213 All SZGR 2.0 genes in this pathway
JOHNSTONE PARVB TARGETS 2 DN 336 211 All SZGR 2.0 genes in this pathway
GOBERT OLIGODENDROCYTE DIFFERENTIATION UP 570 339 All SZGR 2.0 genes in this pathway